Marinomed Biotech AG
About Marinomed Biotech AG
Categories
-
Country/Region:Austria
-
On CPHI since:2020
-
Employees:25 - 49
Company types
Primary activities
Products from Marinomed Biotech AG (3)
-
Product Tacrosolv – a novel Marinosolv enabled solution
Marinosolv technology significantly extends ocular tissue penetration, enabling a faster onset of efficacy due to high bioavailability of active pharmaceutical ingredients, while enhancing tolerability and safety through a substantial reduction in dosage and minimized systemic exposure.
-
Product Budesolv
Marinosolv® – The Enabling Technology Behind BudesolvBudesolv is an innovative aqueous budesonide formulation based on Marinosolv® drug delivery platform, which has the potential to dramatically improve the solubility and bioavailability of poorly water-soluble compounds. This leads to faster therapeu... -
Product Solv4U
Marinosolv® enables a strongly increased solubilization and thereby enhanced bioavailability of hydrophobic small molecules and peptides. Consequently, more efficient treatments of a multitude of diseases can be envisaged. Marinosolv® technology facilitates targeted drug delivery with a low systemic off-ta...
